Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan/HCTZ in Chinese Patients with Hypertension
NCT00872586Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan, hydrochlorothiazide in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started Aug 2006; status: completed.
02
Drugs
olmesartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00872586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872586.